Mira Pharma(MIRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MIRA Mira Pharma

Pre-Mkt 10-30 07:22:17 EDT

0.5716

+0.0155

+2.79%

盘前0.5900

+0.0184+3.22%

06:41 EDT

High0.6300	Low0.5519	Vol380.57K
Open0.5740	D1 Closing0.5561	Amplitude14.04%
Mkt Cap23.94M	Tradable Cap22.12M	Total Shares41.88M
T/O223.22K	T/O Rate0.98%	Tradable Shares38.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MIRA","market":"US","secType":"STK","nameCN":"Mira Pharma","latestPrice":0.5716,"timestamp":1793304000000,"preClose":0.5561,"halted":0,"volume":380568,"hourTrading":{"tag":"盘前","latestPrice":0.59,"preClose":0.5716,"latestTime":"06:41 EDT","volume":495,"amount":277.705593,"timestamp":1793356906542,"change":0.0184,"changeRate":0.03219,"amplitude":0.052484},"delay":0,"changeRate":0.027872684768926376,"floatShares":38692800,"shares":41876087,"eps":-1.3802,"marketStatus":"Pre-Mkt","change":0.0155,"latestTime":"10-30 07:22:17 EDT","open":0.574,"high":0.63,"low":0.5519,"amount":223215.40151232,"amplitude":0.140442,"askPrice":0.6835,"askSize":100,"bidPrice":0.56,"bidSize":895,"shortable":3,"etf":0,"ttmEps":-1.3802,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793367000000},"marketStatusCode":1,"adr":0,"listingDate":1691035200000,"exchange":"NASDAQ","adjPreClose":0.5716,"preHourTrading":{"tag":"盘前","latestPrice":0.59,"preClose":0.5716,"latestTime":"06:41 EDT","volume":495,"amount":277.705593,"timestamp":1793356906542,"change":0.0184,"changeRate":0.03219,"amplitude":0.052484},"postHourTrading":{"tag":"盘后","latestPrice":0.6,"preClose":0.5716,"latestTime":"19:36 EDT","volume":8081,"amount":4789.20476,"timestamp":1793316988512,"change":0.0284,"changeRate":0.049685,"amplitude":0.073478},"volumeRatio":1.5037234050929316},"requestUrl":"/m/hq/s/MIRA/tweets","defaultTab":"tweets","newsList":[{"id":"2679401576","title":"Mira Pharmaceuticals Reports Significant Weight and Fat Reduction with Oral Skny-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared with Semaglutide","url":"https://stock-news.laohu8.com/highlight/detail?id=2679401576","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679401576?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:00","pubTimestamp":1793275215,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F1M0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679401514","title":"Mira Pharmaceuticals - Announces Positive Proof-of-Concept Results for Skny-1 in Obesity Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2679401514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679401514?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:00","pubTimestamp":1793275215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F1M0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679412787","title":"MIRA unveils promising preclinical data for oral obesity drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2679412787","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679412787?lang=en_us&edition=fundamental","pubTime":"2026-10-29 04:50","pubTimestamp":1793220659,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has issued an announcement. On October 28–29, 2026, MIRA Pharmaceuticals reported initial proof-of-concept d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mira-unveils-promising-preclinical-data-for-oral-obesity-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mira-unveils-promising-preclinical-data-for-oral-obesity-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679166844","title":"MIRA Pharmaceuticals' Oral SKNY-1 Reduces Weight, Fat in Obese Mice Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2679166844","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679166844?lang=en_us&edition=fundamental","pubTime":"2026-10-29 04:03","pubTimestamp":1793217801,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals' Oral SKNY-1 Reduces Weight, Fat in Obese Mice StudyMIRA Pharmaceuticals reported initial pilot-study results showing oral obesity candidate SKNY-1 reduced weight and fat in obese","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL3zQQtH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679641637","title":"Mira Pharmaceuticals - Skny-1 Weight Reduction Occurs Without Significant Decrease in Food Consumption - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2679641637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679641637?lang=en_us&edition=fundamental","pubTime":"2026-10-29 04:02","pubTimestamp":1793217759,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nFWN46E2HT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679165834","title":"Mira Pharmaceuticals - Skny-1-Treated Mice Do not Show Significant Lean-Mass Loss Compared to Semaglutide - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2679165834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679165834?lang=en_us&edition=fundamental","pubTime":"2026-10-29 04:02","pubTimestamp":1793217759,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nFWN46E2HT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678180784","title":"Analysts Offer Insights on Healthcare Companies: Sutro Biopharma (STRO), Lucid Diagnostics (LUCD) and MIRA Pharmaceuticals, Inc. (MIRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2678180784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678180784?lang=en_us&edition=fundamental","pubTime":"2026-10-25 18:40","pubTimestamp":1792924851,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sutro Biopharma (STRO), Lucid Diagnostics (LUCD) and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sutro-biopharma-stro-lucid-diagnostics-lucd-and-mira-pharmaceuticals-inc-mira-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sutro-biopharma-stro-lucid-diagnostics-lucd-and-mira-pharmaceuticals-inc-mira-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4555","LU0128526141.USD","BK4137","BK4099","HCSG","LABU","LCDL","BK4551","LUCD","BK4596","MIRA","BK4082","LCID","LCIZ","LU0029874061.USD","BK4588","STRO","XLV","BK4585","XBI","BK4581","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677968633","title":"Mira Pharmaceuticals' MIRA-55 Shows Pain Relief Comparable to Celebrex in Rat Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2677968633","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677968633?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:08","pubTimestamp":1792670911,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals' MIRA-55 shows pain relief comparable to Celebrex in rat studyMira Pharmaceuticals’ oral MIRA-55 matched Celebrex’s pain relief at higher doses in a 21-day chronic inflammatory pa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nNDL7388Kb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677968835","title":"Mira Pharmaceuticals Inc: Mira-55 Also Reduced Inflammation-Associated Swelling and was Well Tolerated, with no Adverse Clinical Signs Observed","url":"https://stock-news.laohu8.com/highlight/detail?id=2677968835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677968835?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:00","pubTimestamp":1792670411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN4681D7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677950052","title":"Mira Pharmaceuticals Reports Mira-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2677950052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677950052?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:00","pubTimestamp":1792670411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN4681D7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677683869","title":"Mira : Advancing Mira-55 Toward a Planned Ind Submission in the First Quarter of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2677683869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677683869?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:00","pubTimestamp":1792670411,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN4681D7:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677496883","title":"Mira : Once-Daily Oral Mira-55 Reduced Both Mechanical & Thermal Pain Hypersensitivity (P < 0.001 Versus Vehicle) as from Lowest Dose Used","url":"https://stock-news.laohu8.com/highlight/detail?id=2677496883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677496883?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:00","pubTimestamp":1792670411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN4681D7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677090950","title":"Mira Pharmaceuticals Inc: Results Support Continued Advancement of Mira-55 Toward an Investigational New Drug (Ind) Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2677090950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677090950?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:00","pubTimestamp":1792670411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN4681D7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668995601","title":"MIRA Pharmaceuticals Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2668995601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668995601?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:19","pubTimestamp":1789658340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MIRA/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668967482","title":"MIRA advances Ketamir-2 Phase 2a neuropathy program","url":"https://stock-news.laohu8.com/highlight/detail?id=2668967482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668967482?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:58","pubTimestamp":1789649919,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has provided an update. On Sept. 17, 2026, MIRA Pharmaceuticals announced that its Phase 2a clinical program...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mira-advances-ketamir-2-phase-2a-neuropathy-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mira-advances-ketamir-2-phase-2a-neuropathy-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668671649","title":"Mira advances Ketamir-2 to chemotherapy-induced peripheral neuropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2668671649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668671649?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:45","pubTimestamp":1789649153,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals (MIRA) announced that, following review and comments from the FDA, the Phase 2a protocol evaluating Ketamir-2 in chemotherapy-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mira-advances-ketamir-2-to-chemotherapy-induced-peripheral-neuropathy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mira-advances-ketamir-2-to-chemotherapy-induced-peripheral-neuropathy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","MIRA","LABU","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668296214","title":"MIRA Pharmaceuticals Submits Ketamir-2 Phase 2a CIPN Protocol for IRB Review After FDA Feedback","url":"https://stock-news.laohu8.com/highlight/detail?id=2668296214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668296214?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:32","pubTimestamp":1789648350,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals submits Ketamir-2 Phase 2a CIPN protocol for IRB review after FDA feedbackMira Pharmaceuticals submitted a Phase 2a protocol for Ketamir-2 in chemotherapy-induced peripheral neuro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL3JzwKz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","BCDF","BK4585","LU2095319765.USD","BK4112","NDAQ","LU0314104364.USD","IE00BQXX3F31.USD","SG9999014013.SGD","BK4588","SG9999014039.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210150020.SGD","IE00BQXX3C00.GBP","MIRA","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4007","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962936","title":"Mira Pharmaceuticals - Targets Site Initiation for Phase 2a Ketamir-2 Study in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962936","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962936?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA1NCPJC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962671","title":"Mira Pharmaceuticals - Submits Phase 2a Protocol for Ketamir-2 in Cipn to Irb After FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962671?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA1NCPJC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668629399","title":"Mira Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (Cipn) Following FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2668629399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668629399?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA1NCPJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mirapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.0911},{"period":"1month","weight":-0.3441},{"period":"3month","weight":-0.2783},{"period":"6month","weight":-0.4504},{"period":"1year","weight":-0.6472},{"period":"ytd","weight":-0.6215}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.0068},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.0676},{"period":"1year","weight":0.1192},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.076979},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.024441},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.027651},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.020794},{"month":5,"riseRate":0.666667,"avgChangeRate":0.045339},{"month":6,"riseRate":0,"avgChangeRate":-0.14408},{"month":7,"riseRate":0.666667,"avgChangeRate":0.832369},{"month":8,"riseRate":0,"avgChangeRate":-0.092725},{"month":9,"riseRate":0.25,"avgChangeRate":-0.123916},{"month":10,"riseRate":0.5,"avgChangeRate":0.001592},{"month":11,"riseRate":0.333333,"avgChangeRate":0.101722},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.266745}],"exchange":"NASDAQ","name":"Mira Pharma","nameEN":"Mira Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mira Pharma(MIRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mira Pharma(MIRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mira Pharma,MIRA,Mira Pharma股票,Mira Pharma股票老虎,Mira Pharma股票老虎国际,Mira Pharma行情,Mira Pharma股票行情,Mira Pharma股价,Mira Pharma股市,Mira Pharma股票价格,Mira Pharma股票交易,Mira Pharma股票购买,Mira Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mira Pharma(MIRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mira Pharma(MIRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}